Open Access

Ligustrazine ameliorates acute kidney injury through downregulation of NOD2‑mediated inflammation

  • Authors:
    • Guosheng Jiang
    • Rui Xin
    • Wendan Yuan
    • Lixia Zhang
    • Xianghui Meng
    • Wangnan Sun
    • Huirong Han
    • Yun Hou
    • Lin Wang
    • Pengchao Du
  • View Affiliations

  • Published online on: January 10, 2020     https://doi.org/10.3892/ijmm.2020.4464
  • Pages: 731-742
  • Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ligustrazine has been used to alleviate clinical acute kidney injury (AKI); however, the underlying molecular mechanisms are poorly understood. In order to further elucidate the molecular mechanism underlying its occurrence, the role of nucleotide‑binding oligomerization domain‑containing 2 (NOD2) in AKI was investigated in the present study, and the results indicated that ligustrazine exerts an important protective effect against AKI in vivo by inhibiting the upregulation of NOD2 expression and reducing apoptosis of kidney cells following ischemia/reperfusion injury in rat models. Furthermore, the inhibitory role of ligustrazine on the upregulation of NOD2 and apoptosis of kidney cells induced by CoCl2 and oxygen and glucose deprivation followed by reoxygenation was investigated in in vitro experiments. The effect of ligustrazine on NOD2 downregulation was partially blocked by inhibiting autophagy. To the best of our knowledge, the results of the present study are the first to provide evidence that ligustrazine can inhibit NOD2‑mediated inflammation to protect against renal injury, which may be in part attributed to the induction of autophagy. These findings may help design and develop new approaches and therapeutic strategies for AKI to prevent the deterioration of renal function.
View Figures
View References

Related Articles

Journal Cover

March 2020
Volume 45 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Jiang, G., Xin, R., Yuan, W., Zhang, L., Meng, X., Sun, W. ... Du, P. (2020). Ligustrazine ameliorates acute kidney injury through downregulation of NOD2‑mediated inflammation. International Journal of Molecular Medicine, 45, 731-742. https://doi.org/10.3892/ijmm.2020.4464
MLA
Jiang, G., Xin, R., Yuan, W., Zhang, L., Meng, X., Sun, W., Han, H., Hou, Y., Wang, L., Du, P."Ligustrazine ameliorates acute kidney injury through downregulation of NOD2‑mediated inflammation". International Journal of Molecular Medicine 45.3 (2020): 731-742.
Chicago
Jiang, G., Xin, R., Yuan, W., Zhang, L., Meng, X., Sun, W., Han, H., Hou, Y., Wang, L., Du, P."Ligustrazine ameliorates acute kidney injury through downregulation of NOD2‑mediated inflammation". International Journal of Molecular Medicine 45, no. 3 (2020): 731-742. https://doi.org/10.3892/ijmm.2020.4464